Analyst Tewari holds a conference call with CEO Dr. Michael Thomas Henderson, CFO Jane Henderson and CMO Dambkowski on May 3 at 1 pm hosted by Jefferies.Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APGE:
- Spyre Therapeutics price target raised to $54 from $36 at Stifel
- Apogee Therapeutics Launches Innovative Antibody Clinical Trial
- Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
- Apogee announces first participants dosed in Phase 1 trial of APG808
- Four new option listings on March 20th